Skip to main content
Premium Trial:

Request an Annual Quote

Samplix Receives €1.9M From European Union

NEW YORK (GenomeWeb) — Samplix of Denmark has won €1.9 million ($2.2 million) in funding from the European Union's Horizon 2020 – SME instrument program.

The company plans to use the funding to further develop its Xdrop technology, which allows users to partition millions of single molecules in droplets for targeted enrichment and amplification for sequencing analysis.

The Xdrop technology, which is currently in beta testing with several research institutes, comprises microfluidics, chemistry, and bioinformatics.

Samplix is one of 278 small and medium-sized enterprises from 27 countries receiving funding as part of this round, announced in late December, which totaled €129 million under Phase 2 and €10 million under Phase 1. 

The Scan

Call for a Different Tack

Experts weigh the value of recent experiments testing genetically modified pig kidneys using brain-dead individuals, according to Nature News.

Wastewater Warning

The New York Times reports that wastewater surveillance in some parts of the US point to a possible surge.

Can't Get in the Program

Due to the Northern Ireland protocol dispute, the European Union is preventing UK researchers from joining the Horizon Europe research program, the Times of London reports.

Science Paper on Spatial-Controlled Genome Editing

In Science this week: approach to enable a CRISPR-Cas13a-based system to be used as a cancer therapy.